MapLight Therapeutics (MPLT) Depreciation & Amortization (CF) (2024 - 2025)
MapLight Therapeutics (MPLT) posted Depreciation & Amortization (CF) of $200000.0 for Q4 2025, up 100.0% sequentially from $100000.0 in Q3 2025, and little changed YoY from $201000.0 in Q4 2024.
MapLight Therapeutics (MPLT) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends
MapLight Therapeutics has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $200000.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) changed 0.5% year-over-year to $200000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $701000.0 (changed N/A YoY) and the FY2025 annual result came in at $600000.0, down 14.41% from the prior year.
- Depreciation & Amortization (CF) rose to $200000.0 in Q4 2025 per MPLT's latest filing, from $100000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $201000.0 in Q4 2024 and troughed at $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 40.52 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |